Translational repression of p53 by RNPC1,a p53 target over expressed in lymphomas

Jin Zhang, Seong Jun Cho, Limin Shu, Wensheng Yan, Teri Guerrero, Michael S Kent, Katherine A Skorupski, Hongwu Chen, Xinbin Chen

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

The p53 pathway is critical for tumor suppression, as the majority of human cancer has a faulty p53. Here, we identified RNPC1, a p53 target and a RNA-binding protein, as a critical regulator of p53 translation. We showed that ectopic expression of RNPC1 inhibited, whereas knockdown of RNPC1 increased, p53 translation under normal and stress conditions. We also showed that RNPC1 prevented cap-binding protein eIF4E from binding p53mRNA via its C-terminal domain for physical interaction with eIF4E, and its N-terminal domain for binding p53mRNA. Consistent with this, we found that RNPC1 directly binds to p53 5' and 3'untranslated regions (UTRs).Importantly, we showed that RNPC1 inhibits ectopic expression of p53 in a dose-dependent manner via p53 5' or3' UTR. Moreover, we showed that loss of RNPC1 in mouse embryonic fibroblasts increased the level of p53protein, leading to enhanced premature senescence in a p53-dependent manner. Finally, to explore the clinical relevance of our finding, we showed that RNPC1 was frequently over expressed in dog lymphomas, most of which were accompanied by decreased expression of wild-type p53. Together, we identified a novel p53-RNPC1autoregulatory loop, and our findings suggest that RNPC1 plays a role in tumori genesis by repressing p53translation.

Original languageEnglish (US)
Pages (from-to)1528-1543
Number of pages16
JournalGenes and Development
Volume25
Issue number14
DOIs
StatePublished - Jul 15 2011

Fingerprint

5' Untranslated Regions
Lymphoma
RNA Cap-Binding Proteins
Critical Pathways
RNA-Binding Proteins
3' Untranslated Regions
Protein Binding
Neoplasms
Fibroblasts
Dogs
Ectopic Gene Expression

Keywords

  • eIF4E
  • P53
  • RBM38
  • RNA-binding protein
  • RNPC1
  • Translational control

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Translational repression of p53 by RNPC1,a p53 target over expressed in lymphomas. / Zhang, Jin; Cho, Seong Jun; Shu, Limin; Yan, Wensheng; Guerrero, Teri; Kent, Michael S; Skorupski, Katherine A; Chen, Hongwu; Chen, Xinbin.

In: Genes and Development, Vol. 25, No. 14, 15.07.2011, p. 1528-1543.

Research output: Contribution to journalArticle

@article{dcd9855a401f4b99b00580ded39f37b4,
title = "Translational repression of p53 by RNPC1,a p53 target over expressed in lymphomas",
abstract = "The p53 pathway is critical for tumor suppression, as the majority of human cancer has a faulty p53. Here, we identified RNPC1, a p53 target and a RNA-binding protein, as a critical regulator of p53 translation. We showed that ectopic expression of RNPC1 inhibited, whereas knockdown of RNPC1 increased, p53 translation under normal and stress conditions. We also showed that RNPC1 prevented cap-binding protein eIF4E from binding p53mRNA via its C-terminal domain for physical interaction with eIF4E, and its N-terminal domain for binding p53mRNA. Consistent with this, we found that RNPC1 directly binds to p53 5' and 3'untranslated regions (UTRs).Importantly, we showed that RNPC1 inhibits ectopic expression of p53 in a dose-dependent manner via p53 5' or3' UTR. Moreover, we showed that loss of RNPC1 in mouse embryonic fibroblasts increased the level of p53protein, leading to enhanced premature senescence in a p53-dependent manner. Finally, to explore the clinical relevance of our finding, we showed that RNPC1 was frequently over expressed in dog lymphomas, most of which were accompanied by decreased expression of wild-type p53. Together, we identified a novel p53-RNPC1autoregulatory loop, and our findings suggest that RNPC1 plays a role in tumori genesis by repressing p53translation.",
keywords = "eIF4E, P53, RBM38, RNA-binding protein, RNPC1, Translational control",
author = "Jin Zhang and Cho, {Seong Jun} and Limin Shu and Wensheng Yan and Teri Guerrero and Kent, {Michael S} and Skorupski, {Katherine A} and Hongwu Chen and Xinbin Chen",
year = "2011",
month = "7",
day = "15",
doi = "10.1101/gad.2069311",
language = "English (US)",
volume = "25",
pages = "1528--1543",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "14",

}

TY - JOUR

T1 - Translational repression of p53 by RNPC1,a p53 target over expressed in lymphomas

AU - Zhang, Jin

AU - Cho, Seong Jun

AU - Shu, Limin

AU - Yan, Wensheng

AU - Guerrero, Teri

AU - Kent, Michael S

AU - Skorupski, Katherine A

AU - Chen, Hongwu

AU - Chen, Xinbin

PY - 2011/7/15

Y1 - 2011/7/15

N2 - The p53 pathway is critical for tumor suppression, as the majority of human cancer has a faulty p53. Here, we identified RNPC1, a p53 target and a RNA-binding protein, as a critical regulator of p53 translation. We showed that ectopic expression of RNPC1 inhibited, whereas knockdown of RNPC1 increased, p53 translation under normal and stress conditions. We also showed that RNPC1 prevented cap-binding protein eIF4E from binding p53mRNA via its C-terminal domain for physical interaction with eIF4E, and its N-terminal domain for binding p53mRNA. Consistent with this, we found that RNPC1 directly binds to p53 5' and 3'untranslated regions (UTRs).Importantly, we showed that RNPC1 inhibits ectopic expression of p53 in a dose-dependent manner via p53 5' or3' UTR. Moreover, we showed that loss of RNPC1 in mouse embryonic fibroblasts increased the level of p53protein, leading to enhanced premature senescence in a p53-dependent manner. Finally, to explore the clinical relevance of our finding, we showed that RNPC1 was frequently over expressed in dog lymphomas, most of which were accompanied by decreased expression of wild-type p53. Together, we identified a novel p53-RNPC1autoregulatory loop, and our findings suggest that RNPC1 plays a role in tumori genesis by repressing p53translation.

AB - The p53 pathway is critical for tumor suppression, as the majority of human cancer has a faulty p53. Here, we identified RNPC1, a p53 target and a RNA-binding protein, as a critical regulator of p53 translation. We showed that ectopic expression of RNPC1 inhibited, whereas knockdown of RNPC1 increased, p53 translation under normal and stress conditions. We also showed that RNPC1 prevented cap-binding protein eIF4E from binding p53mRNA via its C-terminal domain for physical interaction with eIF4E, and its N-terminal domain for binding p53mRNA. Consistent with this, we found that RNPC1 directly binds to p53 5' and 3'untranslated regions (UTRs).Importantly, we showed that RNPC1 inhibits ectopic expression of p53 in a dose-dependent manner via p53 5' or3' UTR. Moreover, we showed that loss of RNPC1 in mouse embryonic fibroblasts increased the level of p53protein, leading to enhanced premature senescence in a p53-dependent manner. Finally, to explore the clinical relevance of our finding, we showed that RNPC1 was frequently over expressed in dog lymphomas, most of which were accompanied by decreased expression of wild-type p53. Together, we identified a novel p53-RNPC1autoregulatory loop, and our findings suggest that RNPC1 plays a role in tumori genesis by repressing p53translation.

KW - eIF4E

KW - P53

KW - RBM38

KW - RNA-binding protein

KW - RNPC1

KW - Translational control

UR - http://www.scopus.com/inward/record.url?scp=79960424486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960424486&partnerID=8YFLogxK

U2 - 10.1101/gad.2069311

DO - 10.1101/gad.2069311

M3 - Article

C2 - 21764855

AN - SCOPUS:79960424486

VL - 25

SP - 1528

EP - 1543

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 14

ER -